Literature DB >> 30567746

Evaluation of a Novel Stool Antigen Rapid Test Kit for Detection of Helicobacter pylori Infection.

Toshihiko Kakiuchi1, Masumi Okuda2,3, Kazutoshi Hashiguchi4, Ichiro Imamura4, Aiko Nakayama5, Muneo Matsuo5.   

Abstract

The Quick Chaser H. pylori (QCP), which is a novel antigen detection kit for Helicobacter pylori, was developed recently. The previous examination kits targeted the catalase of H. pylori; however, this new test kit, to the best of our knowledge, is the first kit to target the flagellar protein of H. pylori The present study aimed to evaluate the efficacy of QCP compared with that of the already commercially available rapid test kit Testmate Rapid Pylori Antigen (TRP). TRP and QCP were utilized in 71 participants. The positive and negative concordance ratios of QCP to TRP were 100% (57/57) and 92.9% (13/14), respectively. Sensitivity based on the rapid urease test and culture test was 92.3%. Results of the dilution sensitivity test showed that QCP was eight times more sensitive to an H. pylori standard strain and the clarithromycin (CAM)-resistant clinical isolate and four times more sensitive to a CAM-susceptible clinical isolate than TRP. For the cross-reactivity test, 27 strains that exist in human feces, such as the Helicobacter genus, Bifidobacterium genus, Lactobacillus genus, and other resident bacteria, were selected. The results obtained using QCP were all negative, and no cross-reaction was observed. In conclusion, compared with TRP, QCP can detect H. pylori using clinical specimens with high sensitivity, regardless of CAM susceptibility and tolerance. No cross-reactivity was observed with other intestinal bacteria in humans. The kit is considered extremely useful in clinical settings.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Helicobacter pylorizzm321990; catalase; flagellin; rapid test kit; stool antigen

Mesh:

Substances:

Year:  2019        PMID: 30567746      PMCID: PMC6425190          DOI: 10.1128/JCM.01825-18

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

1.  Introduction of an examination and treatment for Helicobacter pylori infection in high school health screening.

Authors:  Taiji Akamatsu; Shinya Ichikawa; Sadahide Okudaira; Shuichi Yokosawa; Yugo Iwaya; Tomoaki Suga; Hiroyoshi Ota; Eiji Tanaka
Journal:  J Gastroenterol       Date:  2011-08-19       Impact factor: 7.527

2.  Antimicrobial resistance and characteristics of eradication therapy of Helicobacter pylori in Japan: a multi-generational comparison.

Authors:  Takuma Okamura; Tomoaki Suga; Tadanobu Nagaya; Norikazu Arakura; Takehisa Matsumoto; Yoshiko Nakayama; Eiji Tanaka
Journal:  Helicobacter       Date:  2014-04-03       Impact factor: 5.753

3.  Low prevalence of Helicobacter pylori-negative gastric cancer among Japanese.

Authors:  Taiji Matsuo; Masanori Ito; Shunsuke Takata; Shinji Tanaka; Masaharu Yoshihara; Kazuaki Chayama
Journal:  Helicobacter       Date:  2011-12       Impact factor: 5.753

4.  Helicobacter pylori infection and the development of gastric cancer.

Authors:  N Uemura; S Okamoto; S Yamamoto; N Matsumura; S Yamaguchi; M Yamakido; K Taniyama; N Sasaki; R J Schlemper
Journal:  N Engl J Med       Date:  2001-09-13       Impact factor: 91.245

5.  Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups.

Authors:  Wen-Qing Li; Jun-Ling Ma; Lian Zhang; Linda M Brown; Ji-You Li; Lin Shen; Kai-Feng Pan; Wei-Dong Liu; Yuanreng Hu; Zhong-Xiang Han; Susan Crystal-Mansour; David Pee; William J Blot; Joseph F Fraumeni; Wei-Cheng You; Mitchell H Gail
Journal:  J Natl Cancer Inst       Date:  2014-06-12       Impact factor: 13.506

6.  Usefulness of detection of clarithromycin-resistant Helicobacter pylori from fecal specimens for young adults treated with eradication therapy.

Authors:  Takako Osaki; Katsuhiro Mabe; Cynthia Zaman; Hideo Yonezawa; Masumi Okuda; Kenji Amagai; Shinji Fujieda; Mitsuhide Goto; Wataru Shibata; Mototsugu Kato; Shigeru Kamiya
Journal:  Helicobacter       Date:  2017-05-22       Impact factor: 5.753

7.  A Novel Stool PCR Test for Helicobacter pylori May Predict Clarithromycin Resistance and Eradication of Infection at a High Rate.

Authors:  Erin Beckman; Ilaria Saracino; Giulia Fiorini; Courtney Clark; Vladimir Slepnev; Denise Patel; Clarissa Gomez; Reddy Ponaka; Vecheslav Elagin; Dino Vaira
Journal:  J Clin Microbiol       Date:  2017-05-17       Impact factor: 5.948

8.  Detection of mixed clarithromycin-resistant and -susceptible Helicobacter pylori using nested PCR and direct sequencing of DNA extracted from faeces.

Authors:  Norihisa Noguchi; Emiko Rimbara; Ayami Kato; Akifumi Tanaka; Kengo Tokunaga; Takashi Kawai; Shin'ichi Takahashi; Masanori Sasatsu
Journal:  J Med Microbiol       Date:  2007-09       Impact factor: 2.472

9.  Effect of Helicobacter pylori eradication on metachronous gastric cancer after endoscopic resection of gastric tumors: a meta-analysis.

Authors:  Seung Bae Yoon; Jae Myung Park; Chul-Hyun Lim; Yu Kyung Cho; Myung-Gyu Choi
Journal:  Helicobacter       Date:  2014-08       Impact factor: 5.753

10.  Effects of stool dilution on the faecal Helicobacter pylori antigen test.

Authors:  T Shimizu; T Fujii; H Haruna; H Shoji; T Kudo; Y Yamashiro
Journal:  J Paediatr Child Health       Date:  2003 May-Jun       Impact factor: 1.954

View more
  3 in total

Review 1.  Helicobacter pylori Infection, Its Laboratory Diagnosis, and Antimicrobial Resistance: a Perspective of Clinical Relevance.

Authors:  Shamshul Ansari; Yoshio Yamaoka
Journal:  Clin Microbiol Rev       Date:  2022-04-11       Impact factor: 50.129

2.  Clinical Evaluation of a Novel Stool Antigen Test Using Bioluminescent Enzyme Immunoassay for Detecting Helicobacter pylori.

Authors:  Toshihiko Kakiuchi; Muneaki Matsuo; Yasuhisa Sakata; Kazuma Fujimoto
Journal:  Can J Gastroenterol Hepatol       Date:  2022-04-21

Review 3.  What Is New in Helicobacter pylori Diagnosis. An Overview.

Authors:  Maria Pina Dore; Giovanni Mario Pes
Journal:  J Clin Med       Date:  2021-05-13       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.